Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sunil Lakhwani Lakhwani"'
Autor:
María Nieves Saez Perdomo, Ruth Stuckey, Elena González-Pérez, Santiago Sánchez-Sosa, Paula Estupiñan-Cabrera, Sunil Lakhwani Lakhwani, José David González San Miguel, Nuria Hernanz Soler, Marina Gordillo, Gloria González Brito, María Tapia-Torres, Ana Ruano, Adrián Segura-Díaz, Hugo Luzardo, Cristina Bilbao-Sieyro, María Teresa Gómez-Casares
Publikováno v:
Hematology Reports, Vol 16, Iss 1, Pp 140-150 (2024)
Background: Second- and third-generation tyrosine kinase inhibitors (TKIs) are now available to treat chronic-phase chronic myeloid leukemia (CP-CML) in the first and second line. However, vascular adverse events (VAEs) have been reported for patient
Externí odkaz:
https://doaj.org/article/dc6e5c75fbd04bd2b5703f7bc863f566
Autor:
Minerva Montalvo Saavedra, Alvaro Bienert Garcia, Belén Pérez-Pinilla, Paula Reyes González-Casanova, Marta Díaz-Lopez, Jose Gregorio Torres Quiroz, Alberto Martinez Llorens, Cielo de Los Ángeles Lorena Borja Goyeneche, Carolina Lacalzada Higueras, Bernardo Javier González González, Miguel Teodoro Hernandez Garcia, Sunil Lakhwani Lakhwani
Publikováno v:
HemaSphere, Vol 7, p e5390797 (2023)
Externí odkaz:
https://doaj.org/article/1fa2890c5a65405591586008fa18ab1e
Autor:
Jose Maria Raya, Kevin Díaz Gorrín, Annalis Serpa Mule, Carolina Lacalzada -Higueras, Marta Diaz-Lopez, Minerva Montalvo Saavedra, Paula Reyes González-Casanova, Alejandro Martín Martín, Marcelo Barrios, Taida Martín Santos, Sunil Lakhwani Lakhwani, Miguel Teodoro Hernandez Garcia
Publikováno v:
HemaSphere, Vol 7, p e96531fb (2023)
Externí odkaz:
https://doaj.org/article/5cd3f0c6cacd49f0bbf61321431a12d1
Autor:
Belén Pérez-Pinilla, Carolina De Bonis-Braun, Minerva Montalvo Saavedra, Marta Diaz-Lopez, Paula Reyes González-Casanova, María José Rodríguez Salazar, Patricia Machado-Machado, Jose Maria Raya, Miguel Teodoro Hernandez Garcia, Sunil Lakhwani Lakhwani
Publikováno v:
HemaSphere, Vol 7, p e999089d (2023)
Externí odkaz:
https://doaj.org/article/941646e33d6041078bbc7624e4172dff
Autor:
Sunil Lakhwani Lakhwani, Ignacio Artiles Santana, Belén Pérez-Pinilla, Alvaro Bienert Garcia, Minerva Montalvo Saavedra, Marta Díaz-Lopez, Carolina De Bonis-Braun, María José Rodríguez Salazar, Patricia Machado-Machado, Miguel Teodoro Hernandez Garcia, Jose Maria Raya
Publikováno v:
HemaSphere, Vol 7, p e3775323 (2023)
Externí odkaz:
https://doaj.org/article/647f06e7015748519ea7e5c4bc74d1cc
Autor:
Betel Del Rosario García, Jonathan González García, Fernando Gutiérrez Nicolás, Iris González García, Ruth Ramos Díaz, Sunil Lakhwani Lakhwani, Ivette Mourani Padrón, María Micaela Viña Romero, Gloria Julia Nazco Casariego
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 29(1)
Introduction The addition of imatinib to the therapeutic arsenal for chronic myeloid leukaemia (CML) has changed the natural course of the disease, in such a way that it is now considered a chronic pathology. However, to achieve therapeutic success,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caff4d693a46c2bf579292df9a07e7d5
https://pubmed.ncbi.nlm.nih.gov/34661491
https://pubmed.ncbi.nlm.nih.gov/34661491